Balaxi Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
58.05
60.65
55.00
64.95
80.46
Other Income Qtr Cr-1.79-0.130.28-1.01-0.22
Operating Revenues Qtr59.8360.7954.7265.9680.68

*All values are in Cr.

Operating Expenses Qtr
46.37
47.13
43.96
57.12
67.94
Operating Profit Qtr
13.47
13.66
10.76
8.84
12.74
EBIDT Qtr Cr
12.77
15.17
16.69
-38.84
12.52
Depreciation Qtr
0.67
0.48
0.66
0.29
1.19
Net Profit Qtr
10.93
13.59
14.43
-41.34
8.10
Basic EPS Qtr
10.41
13.29
14.10
-40.49
8.01
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -